Market regulator Sebi today disposed the case against one of the employees of Orchid Chemicals and Pharmaceuticals Ltd (OCPL) in a matter related to violations of insider trading norms. Sebi had alleged that P N Deshpande, as an employee of OCPL, had indulged in opposite transactions — buying as well as selling the shares of a company within a period of six months, violating insider trading norms. In its order, the regulator said the quantity of shares involved in the transaction by Deshpande was "miniscule" and the records did not show that by such dealing, he had "acquired wrongful gain or caused any wrongful loss to the others".
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
